Newborn screening requirements; federal Recommended Uniform Screening Panel, evaluation, report.

Senate version adds a specific November 1, 2025 deadline for the Division of Consolidated Laboratory Services to report evaluation findings to committee chairs, whereas the House version required annual status reports to the General Assembly.

Senate version narrows the directive to specifically direct the Division of Consolidated Laboratory Services to evaluate disorders, while the House version assigned this responsibility to the Department of Health.

Version number changed from 25105971D to 25107707D, and committee attribution changed from House Appropriations to Senate Finance and Appropriations.

Formatting and layout changes including spacing adjustments, header reorganization, and line break modifications between the Enrolled and House Substitute versions.

Added amendment to § 32.1-67 regarding follow-up and referral protocols for infants identified with conditions through newborn screening, which was not in the original introduced version.

Added requirement that the Department must assess estimated costs and fiscal impact on test fees when evaluating whether to include new disorders in the screening program.

Added provision stating the Department cannot include disorders not on the RUSP unless it first conducts evaluation and rulemaking as required for RUSP disorders.

Added requirement that the Department must assess estimated costs and fiscal impact on test fees when evaluating whether to include new disorders in the screening program.

Changed implementation timeline: if a condition is added to the screening panel by rule and an available test meets requirements, screening must be implemented within six months of completing rulemaking (previously 36 months after RUSP addition).